PIA
ABBV icon

Perennial Investment Advisors’s AbbVie ABBV Stock Holding History

Perennial Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$927K Sell
4,264
-64
-1% -$14.2K 0.07% 199
2025
Q4 		$989K Buy
4,328
+127
+3% +$28.9K 0.08% 190
2025
Q3 		$973K Buy
4,201
+61
+1% +$12.4K 0.08% 183
2025
Q2 		$768K Buy
4,140
+116
+3% +$21.6K 0.07% 202
2025
Q1 		$843K Buy
4,024
+142
+4% +$27.6K 0.09% 179
2024
Q4 		$690K Buy
3,882
+530
+16% +$97.4K 0.08% 187
2024
Q3 		$662K Buy
3,352
+2
+0.1% +$373 0.09% 178
2024
Q2 		$574K Sell
3,350
-267
-7% -$44.2K 0.08% 181
2024
Q1 		$659K Buy
3,617
+181
+5% +$31.2K 0.1% 163
2023
Q4 		$533K Sell
3,436
-382
-10% -$55.7K 0.09% 172
2023
Q3 		$569K Buy
3,818
+364
+11% +$53.4K 0.1% 159
2023
Q2 		$465K Buy
3,454
+37
+1% +$5.43K 0.08% 187
2023
Q1 		$545K Buy
3,417
+56
+2% +$8.56K 0.1% 163
2022
Q4 		$543K Sell
3,361
-7
-0.2% -$1.07K 0.22% 95
2022
Q3 		$452K Buy
3,368
+322
+11% +$46.2K 0.21% 91
2022
Q2 		$468K Sell
3,046
-70
-2% -$10.7K 0.18% 102
2022
Q1 		$507K Sell
3,116
-91
-3% -$13.2K 0.16% 110
2021
Q4 		$434K Sell
3,207
-85
-3% -$10K 0.14% 138
2021
Q3 		$357K Sell
3,292
-28
-0.8% -$3.2K 0.13% 147
2021
Q2 		$374K Sell
3,320
-226
-6% -$25.5K 0.14% 131
2021
Q1 		$384K Sell
3,546
-249
-7% -$26.6K 0.15% 121
2020
Q4 		$407K Buy
3,795
+656
+21% +$63K 0.17% 102
2020
Q3 		$275K Buy
3,139
+78
+3% +$7.34K 0.14% 117
2020
Q2 		$301K Buy
3,061
+70
+2% +$6.16K 0.2% 97
2020
Q1 		$228K Buy
2,991
+165
+6% +$14.1K 0.2% 98
2019
Q4 		$251K Buy
+2,826
New +$235K 0.2% 109

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perennial Investment Advisors's ABBV Position: Q1 2026 in Review

Perennial Investment Advisors reduced its AbbVie (ABBV) stake by 1.5% in Q1 2026, selling an estimated $14.2K and leaving 4,264 shares worth $927K. The position accounts for 0.07% of the portfolio, ranked #199.

Perennial Investment Advisors first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $989K in Q4 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Perennial Investment Advisors held 4,264 shares of AbbVie worth $927K as of Q1 2026.
  • Perennial Investment Advisors sold 64 AbbVie shares in Q1 2026, an estimated $14.2K.
  • AbbVie made up 0.07% of Perennial Investment Advisors's portfolio in Q1 2026, its #199 holding.
  • Perennial Investment Advisors first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Perennial Investment Advisors's AbbVie position peaked at $989K in Q4 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Perennial Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.